THIRD ROCK VENTURES LP's Net Worth

$610 Million

Estimate Recalculated Feb 22, 2024 05:46PM EST

Who is THIRD ROCK VENTURES LP?

THIRD ROCK VENTURES LP has an estimated net worth of $610 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., AGIOS PHARMACEUTICALS INC, CONSTELLATION PHARMACEUTICALS INC, bluebird bio, Inc., Foundation Medicine, Inc., ZAFGEN, INC., Eleven Biotherapeutics, Inc., and CytomX Therapeutics, Inc..

SEC CIK

THIRD ROCK VENTURES LP's CIK is 0001408591

Past Insider Trading and Trends

2014 was THIRD ROCK VENTURES LP's most active year for acquiring shares with 12 total transactions. THIRD ROCK VENTURES LP's most active month to acquire stocks was the month of January. 2014 was THIRD ROCK VENTURES LP's most active year for disposing of shares, totalling 24 transactions. THIRD ROCK VENTURES LP's most active month to dispose stocks was the month of June. 2018 saw THIRD ROCK VENTURES LP paying a total of $4,079,104.60 for 3,023,033 shares, this is the most they've acquired in one year. In 2015 THIRD ROCK VENTURES LP cashed out on 28,102,237 shares for a total of $403,752,800.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.865

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-25.12%
-1.00M
2.98M
Scheduled
Aug 30
Form 4
+22,487.15%
3.96M
3.98M
Oct 10
Form 3
0
0
No matching records found

CONSTELLATION PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.71%
51.03K
$1.55
$79,099.60
3.03M
Aug 22
Form 4
+26,895.94%
2.97M
$15.00
2.98M
Jul 23
Form 3
0
0
No matching records found

Foundation Medicine, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-828.46K
0
May 14
Form 3
0
0
Form 4/A
-83.19%
-4.10M
$50.00
-$204,938,900.00
828.46K
Apr 7
Form 4
-80.70%
-3.98M
$50.00
-$198,813,900.00
950.96K
Apr 7
Form 4
-25.00%
-1.64M
4.93M
May 12
Form 4
+1,777.04%
6.22M
6.57M
Sep 30
Form 3
0
0
No matching records found

CytomX Therapeutics, Inc. (CTMX) Snapshot price: $1.45

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-23.15%
-1.00M
3.32M
Scheduled
Oct 18
Form 4
-16.44%
-850.00K
4.32M
Scheduled
Jul 13
Form 4
-24.19%
-1.65M
$17.39
-$28,700,395.00
5.17M
Mar 23 - Mar 27
Form 4
-11.08%
-850.00K
6.82M
Scheduled
Mar 15
Form 4
-11.53%
-1.00M
7.67M
Nov 7
Form 4
8.67M
8.67M
Oct 14
Form 3
0
0
No matching records found

Eleven Biotherapeutics, Inc. (CARM) Snapshot price: $2.0099

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1,364.01%
4.51M
$0.06
$8,069.39
4.84M
Feb 11
Form 3
0
0
No matching records found